Andrew E. Schade

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

Peter Chen, Ajay Nirula, Barry N. Heller et al. · New England Journal of Medicine · 2020 · 1.4K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14

Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19

Robert Gottlieb, Ajay Nirula, Peter Chen et al. · JAMA · 2021 · 947 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +15

Efficacy and Safety of Abemaciclib, an Inhibitor of CDK4 and CDK6, for Patients with Breast Cancer, Non–Small Cell Lung Cancer, and Other Solid Tumors

Amita Patnaik, Lee S. Rosen, Sara M. Tolaney et al. · Cancer Discovery · 2016 · 760 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation

Andrew E. Schade, Gary L. Schieven, Robert Townsend et al. · Blood · 2007 · 300 citations · Full text

Life Sciences, Oncology, Pharmacology +14

Association of Donanemab Treatment With Exploratory Plasma Biomarkers in Early Symptomatic Alzheimer Disease

Michael J. Pontecorvo, Ming Lu, Samantha C. Burnham et al. · JAMA Neurology · 2022 · 246 citations · Full text

Medicine, Neurology, Pharmacology +17